CJC-1295 (No DAC)

CJC-1295 (No DAC) is a high-purity, research-grade synthetic peptide widely utilized in laboratory and preclinical studies focused on growth hormone–releasing hormone (GHRH) signaling and endocrine pathway research. As a non–drug affinity complex (No DAC) variant, this peptide is studied for its short-acting interaction with GHRH receptors, allowing researchers to investigate controlled growth hormone release dynamics and receptor-specific signaling mechanisms.

Recognized for its stability and precise receptor activity, CJC-1295 (No DAC) provides a reliable research tool for exploring peptide-mediated endocrine responses and growth hormone regulation without extended systemic exposure.

Key Features:

• Research-grade purity with strict batch-to-batch quality control

• Optimized for in vitro and preclinical research applications

• Short-acting GHRH analog suitable for controlled signaling studies

• Supports research into growth hormone release and endocrine pathway modulation

• Supplied with detailed handling, storage, and reconstitution instructions to maintain peptide stability

Applications:

• Investigating GHRH-mediated growth hormone secretion

• Studying pituitary receptor interactions and peptide signaling dynamics

• Preclinical research into endocrine regulation and hormonal response pathways

Safety and Handling:
For laboratory research use only. Not intended for human consumption or clinical use. Handle in accordance with standard laboratory safety procedures and store under recommended conditions to preserve peptide integrity and stability.